Stage I Breast Cancer: Hu's Patient Story

Patient Info: Hu Jia, Female | Stage I

As of 2023, Hu Jia was in treatment for Stage I breast cancer after choosing a modified plan that excluded lymphadenectomy, while anticipating future medication costs and focusing on diet, art, reflection, and emotional resilience.

Our Cancer StoriesRead more →

Stage IV Breast Cancer: Anna's Patient Story

Patient Info: Anna, Female, 60s | Stage IV

As of 2023, Anna was living with Stage IV breast cancer and receiving treatment that included lumpectomy surgery, hormone therapy, and targeted therapy as her plan.

Our Cancer StoriesRead more →

Stage II Breast Cancer: Annie's Patient Story

Patient Info: Annie, Female, 40s | Stage II

As of 2023, Annie was still receiving care for Stage II breast cancer after completing chemotherapy and hormonal therapy, with lumpectomy, lymphadenectomy, radiation therapy, and immunotherapy still ahead in her plan.

Our Cancer StoriesRead more →

Stage IV Breast Cancer: Aria's Patient Story

Patient Info: Aria, Female, 50s | Stage IV

As of 2023, Aria was living with Stage IV breast cancer and undergoing hormone therapy after choosing not to have recommended surgery.

Our Cancer StoriesRead more →

Breast Cancer: Mina's Patient Story

Patient Info: Mina

Mina completed surgery and radiation treatment and remained on hormone therapy.

Our Cancer StoriesRead more →

Breast Cancer: Grace's Patient Story

Patient Info: Grace

Grace remained on medication after lumpectomy, lymph-node surgery, radiation therapy, and hormone therapy for breast cancer diagnosed through routine testing.

Our Cancer StoriesRead more →

Breast Cancer: Teri's Survivor Story

Patient Info: Teri

Her cancer is in remission, and she continues hormone therapy.

Our Cancer StoriesRead more →

Stage IV HR-Positive Breast Cancer: Bethany's Patient Story

Patient Info: Bethany, Female, Under 40 | Stage IV

Biomarkers: ER-positive / hormone-positive

Metastatic Site: Liver; bones; lymph nodes; stomach

As of December 2022, Bethany was living with Stage IV metastatic breast cancer after recurrence to the liver, bones, lymph nodes, and stomach, and was on lifelong maintenance treatment after disease shrinkage.

The Patient StoryRead more →

Recurrent Malignant Ovarian Steroid Cell Tumor Treated With Multiple Therapies

Patient Info: Anonymized, Female

Biomarkers: PIK3CA, and ATM mutations; ER negative; PR negative

She experienced repeated pelvic and lung recurrences. Platinum-based treatment produced a complete PET-CT response and olaparib maintenance provided about 1 year without progression before a 5 mm lung recurrence was surgically removed.

PubMed CentralRead more →

Breast Cancer: Mary's Survivor Story

Patient Info: Mary Richichi, female, 70+

Biomarkers: hormone receptor-positive

Mary’s breast cancer was described as under control and in remission after treatment.

Dana-FarberRead more →

Malignant Struma Ovarii Managed With Surgery and Long-Term Surveillance

Patient Info: Anonymized, Female

Biomarkers: BRAF mutation negative

She remained asymptomatic with thyroid-stimulating hormone at the treatment goal and entered long-term thyroglobulin surveillance.

PubMed CentralRead more →

Stage IV PIK3CA Breast Cancer: Abigail's Patient Story

Patient Info: Abigail, Female, Under 40 | Stage IV

Biomarkers: Hormone-positive breast cancer with PIK3CA mutation and germline ATM mutation; later PD-L1 somatic change reported. HER2 not stated.

Metastatic Site: Bone, including femurs, spine, and humeri; later liver

As of October 2022, Abigail was living with Stage IV hormone-positive metastatic breast cancer after years of treatment, bone-dominant disease that later involved the liver, targeted therapies, genomic testing, and advocacy around clinical trials and patient research participation.

The Patient StoryRead more →

Teacher travels 600 miles for Dana-Farber care

Patient Info: Pam Zwemer, 50s | Stage IV

Metastatic Site: bone, stomach lining

11+ years after her original breast cancer diagnosis, she was living with Stage IV disease after bone recurrence in 2008 and spread to the stomach lining in 2011, while continuing clinical-trial care and working as a teacher.

Dana-FarberRead more →

Stage III Breast Cancer: Sandra's Patient Story

Patient Info: Sandra Morales, Female, 40s | Stage III

Sandra is doing well, sees her oncologist twice a year, and continues hormone-blocking therapy to reduce recurrence risk.

Stage IV Breast Cancer: Fleur's Patient Story

Patient Info: Fleur Profinet, Female, 40s | Stage IV

As of May 2022, Fleur was living with metastatic breast cancer; she said chemotherapy, targeted therapy, and hormone therapy had made her metastases “sleep,” while fatigue, pain, and mood changes continued.

YouTube (FR search)Read more →

Invasive Lobular Carcinoma: Daneen's Survivor Story

Patient Info: Daneen, Female, 50s

Daneen underwent double mastectomy and reconstruction, started radiation and had been taking anastrozole for 2 years when she shared her story.

Lobular Breast Cancer AllianceRead more →

Stage I HR-Positive Breast Cancer: Faye's Patient Story

Patient Info: Faye Ruopp, Female, 60s | Stage I

Biomarkers: ER-positive

Completed lumpectomy and radiation and began long-term hormone therapy in September 2014.

Dana-FarberRead more →

Metastatic Follicular Carcinoma Arising From Struma Ovarii

Patient Info: Anonymized, Female | Stage Metastatic/Advanced

Metastatic Site: right fallopian tube|peritoneum|omentum|bladder…

Four years after diagnosis, she had no evidence of recurrence or metastasis while continuing thyroid-hormone suppression and 6-monthly surveillance.

PubMed CentralRead more →

Stage I Breast Cancer: Lorena's Patient Story

Patient Info: Lorena, Female | Stage I

As of April 2022, Lorena was nearly 3 years into recovery from Stage I breast cancer after double mastectomy with immediate reconstruction and ongoing tamoxifen.

Invasive Lobular Carcinoma: Jo's Survivor Story

Patient Info: Jo, Female, 50s

Jo recovered well from bilateral mastectomy and reconstruction. She remained on monthly Zoladex and daily anastrozole, with no chemotherapy or radiation required.

Lobular Breast Cancer AllianceRead more →

Recurrent Lobular Breast Cancer Spread to the Opposite Armpit Lymph Node

Patient Info: Anonymized, Female, 60s | Stage IV

Biomarkers: ER-positive; PR-positive; HER2-negative

Metastatic Site: Contralateral right axillary lymph node

After surgery for the recurrence and removal of the opposite-side axillary nodes, the patient proceeded with adjuvant chemotherapy and remained in active treatment.

PubMed CentralRead more →

Invasive Lobular Carcinoma: Stephanie's Patient Story

Patient Info: Stephanie, Female, 60s

As of February 2022, Stephanie was living with locoregional recurrent ILC after extensive surgery and ongoing treatment with Ibrance/Femara, with recent bone, abdomen, and chest scans showing no new cancer growth and continued Femara without chemotherapy.

Lobular Breast Cancer AllianceRead more →

Stage I Invasive Lobular Carcinoma: Virgie's Patient Story

Patient Info: Virgie Shaw, Female, 70+ | Stage I

As of January 2022, Virgie had Stage I invasive lobular carcinoma removed by partial mastectomy, lymph node biopsy was negative, there were no signs of spread, and she needed no further treatment except regular hormonal therapy medication.

Cleveland ClinicRead more →

Stage III Breast Cancer: Carmen's Survivor Story

Patient Info: Carmen, Female, 50s | Stage III

Carmen was declared cancer-free in February 2023 after surgery and follow-up examinations, while continuing hormone therapy and pain medication.

Our Cancer StoriesRead more →